UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
--------------------------------------------------------------------------------
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
April 2007
Barclays PLC and
Barclays Bank PLC
(Names of Registrants)
1 Churchill Place
London E14 5HP
England
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No x
If "Yes" is marked, indicate below the file number assigned to the registrant
in connection with Rule 12g3-2(b):
--------------------------------------------------------------------------------
This Report is a joint Report on Form 6-K filed by Barclays PLC and Barclays
Bank PLC. All of the issued ordinary share capital of Barclays Bank PLC is
owned by Barclays PLC.
This Report comprises:
Information given to The London Stock Exchange and furnished pursuant to
General Instruction B to the General Instructions to Form 6-K.
--------------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, each of
the registrants has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
BARCLAYS PLC
(Registrant)
Date: April 02, 2007 By: /s/ Patrick Gonsalves
----------------------
Patrick Gonsalves
Deputy Secretary
BARCLAYS BANK PLC
(Registrant)
Date: April 02, 2007 By: /s/ Patrick Gonsalves
----------------------
Patrick Gonsalves
Joint Secretary
EXHIBIT INDEX
1) Blocklisting Interim Review dated 01 March 2007
2) Blocklisting Interim Review dated 01 March 2007
3) Blocklisting Interim Review dated 01 March 2007
4) Blocklisting Interim Review dated 01 March 2007
5) Blocklisting Interim Review dated 01 March 2007
6) Director/PDMR Shareholding dated 02 March 2007
7) Partial Repurchase dated 02 March 2007
8) Director/PDMR Shareholding dated 06 March 2007
9) Absa Directorate Change dated 07 March 2007
10) Partial Repurchase dated 08 March 2007
11) Director/PDMR Shareholding dated 09 March 2007
12) Full Redemption dated 13 March 2007
13) Director/PDMR Shareholding dated 13 March 2007
14) Full Redemption dated 13 March 2007
15) Partial Repurchase dated 14 March 2007
16) Partial Repurchase dated 14 March 2007
17) Full Redemption dated 15 March 2007
18) Full Redemption dated 15 March 2007
19) Director/PDMR Shareholding dated 16 March 2007
20) Partial Repurchase dated 20 March 2007
21) Holding(s) in Company dated 20 March 2007
22) Director/PDMR Shareholding dated 20 March 2007
23) Statement re Enron dated 20 March 2007
24) Publication of Final Terms dated 23 March 2007
25) Director/PDMR Shareholding dated 26 March 2007
26) Total Voting Rights dated 30 March 2007
EXHIBIT 1
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically.
To: The FSA
Date: __1 March 2007__
Name of applicant: Barclays PLC
Name of scheme: Renewed 1986 Executive Share Option Scheme
Period of return: From: 10.07.06 To: 31.12.06
Balance under scheme 1,092,924 Ordinary Shares of 0.25p each
from previous return:
The amount by which the
block scheme has been
increased, if the scheme
has been increased since
the date of the last
return: 0
Number of securities 217,650 Ordinary Shares of 0.25p each
issued/allotted under
scheme during period:
Balance under scheme 875,274 Ordinary Shares of 0.25p each
not yet issued/allotted
at end of period
Number and class of 600,000 Ordinary Shares of GBP1 on 06.10.99
securities originally 750,000 Ordinary Shares of GBP1 on 09.11.01
listed and the date of 2,340,300 Ordinary Shares of 0.25p each on 29.04.02
admission 2,000,000 Ordinary Shares of 0.25p each on 12.11.03
500,000 Ordinary Shares of 0.25p each on 31.08.05
1,000,000 Ordinary Shares of 0.25p each on 28.11.05
700,000 Ordinary Shares of 0.25p each on 06.03.06
Total number of
securities in issue at
the end of the period 6,534,698,021
Name of contact: Marie Smith
Address of contact: 1 Churchill Place, London E14 5HP
Telephone number of contact: 020 7116 2907
SIGNED BY ______________________________________________
Director/company secretary/suitably experienced employee/duly authorised
officer, for and on behalf of
_Barclays PLC______________________________________________
Name of applicant
If you knowingly or recklessly give false or misleading information you may be
liable to prosecution.
EXHIBIT 2
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically.
To: The FSA
Date: __1 March____2007__
Name of applicant: Barclays PLC
Name of scheme: Barclays Incentive Share Option Plan
Period of return: From: 10.07.06 To: 31.12.06
Balance under scheme 322,774 Ordinary Shares of 0.25p each
from previous return:
The amount by which 12,500,000 Ordinary Shares of 0.25p each on 21.01.05
the block scheme
has been increased,
if the scheme has been
increased since the
date of the last return:
Number of securities 9,079,846 Ordinary Shares of 0.25p each
issued/allotted under
scheme during period:
Balance under scheme 3,742,928 Ordinary Shares of 0.25p each
not yet issued/allotted
at end of period
Number and class of 600,000 Ordinary Shares of GBP1 on 06.10.99
securities originally 750,000 Ordinary Shares of GBP1 on 09.11.01
listed and the date of 2,340,300 Ordinary Shares of 0.25p each on 29.04.02
admission 2,000,000 Ordinary Shares of 0.25p each on 10.07.03
2,500,000 Ordinary Shares of 0.25p each on 22.07.04
2,000,000 Ordinary Shares of 0.25p each on 04.11.04
500,000 Ordinary Shares of 0.25p each on 16.08.05
2,000,000 Ordinary Shares of 0.25p each on 31.08.05
5,000,000 Ordinary Shares of 0.25p each on 28.11.05
14,000,000 Ordinary Shares of 0.25p each on 06.03.06
2,500,000 Ordinary Shares of 0.25p each on 09.08.06
10,000,000 Ordinary Shares of 0.25p each on 27.10.06
Total number of
securities in issue at
the end of the period 6,534,698,021
Name of contact: Marie Smith
Address of contact: 1 Churchill Place, London E14 5HP
Telephone number of contact: 020 7116 2907
SIGNED BY ______________________________________________
Director/company secretary/suitably experienced employee/duly authorised
officer, for and on behalf of
_Barclays PLC______________________________________________
Name of applicant
If you knowingly or recklessly give false or misleading information you may be
liable to prosecution.
EXHIBIT 3
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically.
To: The FSA
Date: __1 March 2007__
AVS No: 458240
Name of applicant: Barclays PLC
Name of scheme: Woolwich SAYE Share Option Scheme
Period of return: From: 10.07.06 To: 31.12.06
Balance under scheme 808,581 Ordinary Shares of 0.25p each
from previous return:
The amount by which the
block scheme has been
increased, if the scheme
has been increased since
the date of the last
return: 0
Number of securities
issued/allotted under
scheme during period: 0
Balance under scheme not 808,581 Ordinary Shares of 0.25p each
yet issued/allotted at
end of period
Number and class of 500,000 Ordinary Shares of GBP1 on 26.10.00
securities originally 1,822,748 Ordinary Shares of 0.25p each on 29.04.02
listed and the date of
admission
Total number of
securities in issue at
the end of the period 6,534,698,021
Name of contact: Marie Smith
Address of contact: 1 Churchill Place, London E14 5HP
Telephone number of contact: 020 7116 2907
SIGNED BY ______________________________________________
Director/company secretary/suitably experienced employee/duly authorised
officer, for and on behalf of
_Barclays PLC______________________________________________
Name of applicant
If you knowingly or recklessly give false or misleading information you may be
liable to prosecution.
EXHIBIT 4
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically.
To: The FSA
Date: __1 March 2007__
Name of applicant: Barclays PLC
Name of scheme: Woolwich Executive Share Option Plan (ESOP)
Period of return: From: 10.07.06 To: 31.12.06
Balance under scheme 725,988 Ordinary Shares of 0.25p each
from previous return:
The amount by which the
block scheme has been
increased, if the scheme
has been increased since
the date of the last
return: 0
Number of securities 163,336 Ordinary Shares of 0.25p each
issued/allotted under
scheme during period:
Balance under scheme not 562,652 Ordinary Shares of 0.25p each
yet issued/allotted at
end of period
Number and class of 600,000 Ordinary Shares of GBP1 on 06.10.99
securities originally 750,000 Ordinary Shares of GBP1 on 09.11.01
listed and the date of 2,340,300 Ordinary Shares of 0.25p each on 29.04.02
admission 2,000,000 Ordinary Shares of 0.25p each on 10.07.03
5,000,000 Ordinary Shares of 0.25p each on 12.11.03
500,000 Ordinary Shares of 0.25p each on 31.08.05
500,000 Ordinary Shares of 0.25p each on 28.11.05
250,000 Ordinary Shares of 0.25p each on 06.03.06
Total number of
securities in issue at
the end of the
period 6,534,698,021
Name of contact: Marie Smith
Address of contact: 1 Churchill Place, London E14 5HP
Telephone number of contact: 020 7116 2907
SIGNED BY ______________________________________________
Director/company secretary/suitably experienced employee/duly authorised
officer, for and on behalf of
_Barclays PLC______________________________________________
Name of applicant
If you knowingly or recklessly give false or misleading information you may be
liable to prosecution.
EXHIBIT 5
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically.
To: The FSA
Date: __1 March __2007__
Name of applicant: Barclays PLC
Name of scheme: Renewed 1981 & 1991 SAYE Share Option Scheme
Period of return: From: 10.07.06 To: 31.12.06
Balance under scheme
from previous return: 4,299,425 Ordinary Shares of 0.25p each
The amount by which the
block scheme has been
increased, if the
scheme has been
increased since the
date of the last
return: 20,000,000 Ordinary Shares of 0.25p each
Number of securities 16,334,531 Ordinary Shares of 0.25p each
issued/allotted under
scheme during period:
Balance under scheme 7,964,894 Ordinary Shares of 0.25p each
not yet issued/allotted
at end of period
Number and class of 9,000,000 Ordinary Shares of GBP1 on 26.10.00
securities originally 9,000,000 Ordinary Shares of GBP1 on 09.11.01
listed and the date 7,334,244 Ordinary Shares of 0.25p each on 29.04.02
of admission 20,000,000 Ordinary Shares of 0.25p each on 05.11.02
25,000,000 Ordinary Shares of 0.25p each on 10.07.03
3,000,000 Ordinary Shares of 0.25p each on 22.09.03
25,000,000 Ordinary Shares of 0.25p each on 22.07.04
25,000,000 Ordinary Shares of 0.25p each on 28.10.05
20,000,000 Ordinary Shares of 0.25p each on 27.10.06
Total number of
securities in issue at
the end of the period 6,534,698,021
Name of contact: Marie Smith
Address of contact: 1 Churchill Place, London E14 5HP
Telephone number of contact: 020 7116 2907
SIGNED BY ______________________________________________
Director/company secretary/suitably experienced employee/duly authorised
officer, for and on behalf of
_Barclays PLC______________________________________________
Name of applicant
If you knowingly or recklessly give false or misleading information you may be
liable to prosecution.
EXHIBIT 6
2 March 2007
Director/PDMR shareholding: Disclosure and Transparency Rules
3.1.4R(1)(a) and 3.1.4R(1)(b)
Mr J S Varley, a Director of Barclays PLC ("the Company"), notified the Company
on 1 March 2007 that, on 1 March 2007, he had exercised Sharesave options over
4,096 ordinary shares in the Company at a price of 411.00p per share.
The revised total shareholding for Mr Varley following this transaction is
379,182 ordinary shares.
EXHIBIT 7
Barclays PLC
Barclays - ISIN XS0247512873 - Maturity Date 17 May 2045
- Nominal BRL 18,865,000 Please be
advised that the above issue has been repurchased for BRL 4,100,000 on 23
February 2007. The outstanding balance will therefore be BRL 14,765,000
Please amend your records accordingly.
EXHIBIT 8
6 March 2007
Director/PDMR shareholding: Disclosure and Transparency Rules
3.1.4R(1)(a) and 3.1.4R(1)(b)
The independent trustee of the Barclays Group (ESAS) Employees' Benefit Trust
(the "ESAS Trust") notified Barclays PLC ("the Company") on 5 March 2007 that it
had between 27 February 2007 and 28 February 2007 exercised its discretion and
released a total of 45,821 ordinary shares in Barclays PLC and between 26
February 2007 and 2 March 2007 it purchased 22,664,616 ordinary shares in
Barclays PLC at an average price of 729.25 pence per share. None of the shares
released were in respect of an award made to a director of Barclays PLC.
Following these transactions, the trustees of all the Barclays Group employees'
benefit trusts hold a total of 203,764,684 ordinary shares in Barclays PLC. The
executive directors of Barclays PLC are amongst the potential beneficiaries
under these trusts and are therefore regarded for Companies Act purposes as
being interested in the Barclays PLC ordinary shares held in them.
EXHIBIT 9
ABSA GROUP LIMITED ABSA BANK LIMITED
(Incorporated in the (Incorporated in the
Republic of South Africa) Republic of South Africa)
(Registration number: 1986/003934/06) (Registration number: 1986/004794/06)
ISIN: ZAE000067237 ISIN: ZAE000079810
JSE share code: ASA JSE share code: ABSP
Issuer code: AMAGB (Absa Bank)
(Absa, Absa Group or the Group)
PROF. GILL MARCUS APPOINTED TO SUCCEED DR. DANIE CRONJE AS INDEPENDENT
CHAIRPERSON OF ABSA GROUP AND ABSA BANK
Absa Group and Absa Bank announce the following changes to their boards.
Prof. Gill Marcus has been selected by the Absa board to succeed Dr. Danie
Cronje as chair of Absa Group and Absa Bank. Her appointment will be effective
from 1 July 2007, subject to regulatory approval. Dr. Cronje will step down as
chairman on 1 July 2007, but will remain as a director of Absa Group and Absa
Bank until the end of July, to facilitate a smooth handover.
Prof. Marcus is former Deputy Minister of Finance and former Deputy Governor of
the South African Reserve Bank. She is currently Executive Chairperson of
Western Areas Limited and Professor in Policy, Leadership and Gender Studies at
the Gordon Institute of Business Science (GIBS).
The appointment of Prof. Marcus follows an announcement by Absa in April 2006
that Dr. Cronje had informed the respective boards of his decision to retire as
chairman and a director of the Group and the Bank. Absa announced at the time
that it had initiated a process to select a successor to Dr. Cronje and that the
new chairperson would be an independent appointment. Dr. Cronje will continue to
sit on the board of Barclays PLC.
Enquiries
Danie Cronje
Group chairman
(+2711) 350-4235
e-Mail: dcronje@absa.co.za
Issued by:
Jacques Badenhorst
Head: Investor Relations
Absa Group Limited
4th floor, Absa Towers East, 170 Main Street, Johannesburg
Tel: (+2711) 350-4061 Fax: (+2711) 350-6487
e-Mail: jacques.badenhorst@absa.co.za
Lead sponsor:
Merrill Lynch South Africa (Proprietary) Limited
Co-sponsor:
Absa Capital - Corporate Finance, a division of Absa Bank Limited
Barclays PLC
For further information, please contact:
Investor Relations Media Relations
Mark Merson/James Johnson Jason Nisse/Alistair Smith
+44 (0) 20 7166 5752/2927 +44 (0) 20 7116 6223/6132
Johannesburg
7 March 2007
EXHIBIT 10
013fBarclays Bank PLC
Barclays ISIN XS0248523853 - Series 5891
- Maturity Date 17 May 2045
- Nominal BRL 4,130,000
Please be advised that the above issue has been repurchased for BRL 1,200,000 on
23 February 2007.
The outstanding balance will therefore be BRL 2,930,000.
Please amend your records accordingly.
EXHIBIT 11
9 March 2007
Director/PDMR shareholding: Disclosure and Transparency Rules
3.1.4R(1)(a) and 3.1.4R(1)(b)
1. The trustee of the Barclays Group Sharepurchase Plan ("the Plan"), an HM
Revenue and Customs approved all-employee share plan, informed Barclays PLC
("the Company") on 8 March 2007 that it had on 7 March 2007 purchased, and
now held as bare trustee of the Plan, the following ordinary shares in the
capital of the Company for the following directors/Persons Discharging
Managerial Responsibility (PDMRs) at a price of 717.00p per share:
Director/PDMR Number of Shares
Mr G A Hoffman 17
Mr J S Varley 17
The Plan includes Matching Shares provided by the Company on a 1:1 basis up
to the first GBP600 per annum invested by the participant under the Plan.
The number of shares purchased on 7 March 2007 for each director/PDMR above
includes any Matching Shares.
The revised total shareholding for each director following these
transactions is as follows:
Director Beneficial Holding Non Beneficial
Holding
Mr G A Hoffman 319,236 -
Mr J S Varley 379,199 -
In addition to these transactions, the trustees of all the Barclays Group
employees' benefit trusts hold a total of 203,764,684 ordinary shares in the
Company. The executive directors of the Company are amongst the potential
beneficiaries under these trusts and are therefore regarded for Companies
Act purposes as being interested in the ordinary shares in the Company held
in them.
2. Mr Robert E Diamond Jr, a director of the Company notified the Company on 9
March 2007 that, on 7 March 2007, he transferred 100 ordinary shares in the
Company as a gift for nil consideration. The revised total shareholding for
Mr Diamond following the transaction is 2,731,482 ordinary shares.
EXHIBIT 12
13 March 2007
Barclays Bank PLC
Barclays redeems GBP300,000,000 Floating Rate Subordinated Notes
due 2012 (the "Notes")
ISIN: XS0074095679
Barclays Bank PLC announced today, 13 March 2007, that in accordance with an
option to redeem conferred by the terms of the Notes, it redeemed the Notes in
whole on 12 March 2007.
The Notes will be cancelled and there are no further Notes outstanding.
EXHIBIT 13
13 March 2007
Director/PDMR shareholding: Disclosure and Transparency Rules
3.1.4R(1)(a) and 3.1.4R(1)(b)
1. The independent trustee of the Barclays Group (ESAS) Employees' Benefit
Trust (the "ESAS Trust") notified Barclays PLC ("the Company") on 12 March
2007 that it had between 5 March 2007 and 7 March 2007 exercised its
discretion and released a total of 56,062 ordinary shares in Barclays PLC
and between 5 March 2007 and 9 March 2007 it purchased 11,911,210 ordinary
shares in Barclays PLC at an average price of 711.23 pence per share. None
of the shares released were in respect of an award made to a director of
Barclays PLC.
2. The independent trustee of the Barclays Group (PSP) Employees' Benefit
Trust (the "PSP Trust") notified the Company on 12 March 2007 that it had
on 9 March 2007 exercised its discretion and purchased a total of 475,528
ordinary shares in Barclays PLC at a price of 736.00 pence per share.
3. The independent trustee of the Barclays Group (ESAS) Employees' Benefit
Trust notified Barclays PLC ("the Company") on 12 March that it had on 7
March 2007 exercised its discretion and released a total of 49,119 ordinary
shares in the Company to Mr G A Hoffman, a Director of the Company, as
follows:
Share Scheme Shares released Shares sold on Shares
to Director behalf of Director retained by
Director
ESAS 1998 18,538 7,601 10,937
ESAS 2001 30,581 12,539 18,042
The revised total shareholding for Mr Hoffman following these transactions
is 348,215 ordinary shares.
Following these transactions, the trustees of all the Barclays Group employees'
benefit trusts hold a total of 216,095,360 ordinary shares in Barclays PLC. The
executive directors of Barclays PLC are amongst the potential beneficiaries
under these trusts and are therefore regarded for Companies Act purposes as
being interested in the Barclays PLC ordinary shares held in them.
EXHIBIT 14
13 March 2007
Barclays Bank PLC
Barclays redeems GBP300,000,000 Floating Rate Subordinated Notes
due 2012 (the "Notes")
ISIN: XS0074095679
Barclays Bank PLC announced today, 13 March 2007, that in accordance with an
option to redeem conferred by the terms of the Notes, it redeemed the Notes in
whole on 12 March 2007.
The Notes will be cancelled and there are no further Notes outstanding.
EXHIBIT 15
013fBarclays Bank PLC
Barclays Bank Series S049 ISIN XS0249213520-
Maturity Date 23 Mar 07 - GBP 5,142,000
Please be advised the following issue has been repurchased fo GBP 5,000 on 08
Mar 07.
The outstanding balance will therefore be GBP 5,137,000.
Please amend your records accordingly.
EXHIBIT 16
BARCLAYS BANK PLC
Barclays Bank Series 7363 ISIN XS0271073206-
Maturity Date 25 Apr 08 - EUR 12,900,000
Please be advised the following issue has been repurchased for EUR 600,000 & EUR
150,000 on 08 Mar 07.
The outstanding balance will therefore be EUR 12,150,000.
EXHIBIT 17
15 March 2007
Barclays Bank PLC
Barclays redeems GBP44,000,000 Callable Subordinated Floating Rate Notes
due March 2012 (the "Notes")
ISIN: XS0144725255
Barclays Bank PLC announced today, 15 March 2007, that in accordance with an
option to redeem conferred by the terms of the Notes, it redeemed the Notes in
whole on 14 March 2007.
The Notes will be cancelled and there are no further Notes outstanding.
EXHIBIT 18
15 March 2007
Barclays Bank PLC
Barclays redeems GBP44,000,000 Callable Subordinated Floating Rate Notes
due March 2012 (the "Notes")
ISIN: XS0144725255
Barclays Bank PLC announced today, 15 March 2007, that in accordance with an
option to redeem conferred by the terms of the Notes, it redeemed the Notes in
whole on 14 March 2007.
The Notes will be cancelled and there are no further Notes outstanding.
EXHIBIT 19
16 March 2007
Director/PDMR Shareholding: Disclosure and Transparency Rules
3.1.4R(1)(a) and 3.1.4R(1)(b)
1. The independent trustee of the Barclays Group (ESAS) Employees' Benefit
Trust (the "ESAS Trust") notified the Company on 15 March 2007 that it
had on 13 March 2007 exercised its discretion and purchased a total of
12,043,281 ordinary shares in Barclays PLC at an average price of 719.14p
per share and on 13 March 2007 released a total of 27,438,156 ordinary
shares in Barclays PLC to participants in the Executive Share Award Scheme
("ESAS"). The shares were released following provisional allocations made
by the trustee over Barclays PLC ordinary shares to participants in the
ESAS. Of these shares, the following were released to directors and PDMRs
of Barclays PLC:
Directors Shares Shares sold on Price per Shares retained
/PDMRS released behalf of share by Director/PDMR
to Director/ directors to
PDMRs satisfy withholding
liabilities
Mr N Kheraj 285,459 117,039 715.25 168,420
Mr RE Diamond Jr 1,179,477 499,026 715.25 680,451
Mr GA Hoffman 20,954 8,592 715.25 12,362
Mr JS Varley 35,693 14,635 715.25 21,058
Mr P Idzik 180,417 73,972 715.25 106,445
2. The independent trustee of the Barclays Group (ESAS) Employees' Benefit
Trust (the "ESAS Trust") notified the Company on 15 March 2007 that it
had on 13 March 2007 granted rights in the form of nil cost options to the
directors and PDMRs of Barclays PLC listed below under the Barclays PLC
Executive Share Award Scheme ("ESAS"), to acquire ordinary shares in
Barclays PLC. The ESAS options are exercisable from grant until 5 March
2009 and are granted over a proportion of shares which were originally
provisionally allocated by the trustee under ESAS on 5 March 2004 to the
directors and PDMRs listed below.
The number of shares under option includes an additional number of shares
which have been accrued in respect of dividends received by the trustee
since March 2004. The total exercise price payable on any exercise of an
ESAS option is GBP1.
Director Number of shares granted under option to Directors/PDMRs
Mr GA Hoffman 33,854
Mr N Kheraj 210,557
Mr JS Varley 39,220
The revised total shareholding for each director following these transactions is
as follows:
Director Beneficial Holding
Mr N Kheraj 311,062
Mr RE Diamond Jr 3,411,933
Mr GA Hoffman 360,577
Mr JS Varley 400,257
3. The independent trustee of the Barclays Group (PSP) Employees' Benefit
Trust (the "PSP Trust") notified the Company on 15 March 2007 that it had
on 13 March 2007 exercised its discretion and purchased a total of 8,312,808
ordinary shares in Barclays PLC.
Following these transactions, the trustees of all the Barclays Group employees'
benefit trusts hold a total of 209,013,293 ordinary shares in Barclays PLC. The
executive directors of Barclays are amongst the potential beneficiaries under
these trusts and are therefore regarded for Companies Act purposes as being
interested in the Barclays PLC ordinary shares held in them.
EXHIBIT 20
Barclays Bank PLC
Barclays Bank Series S049 ISIN XS0249213520 -
Maturity Date 23 Mar 07 - GBP 5,173,000
Please be advised that the above issue has been repurchased for GBP 31,000 on 28
Feb 07.
The outstanding balance will therefore be GBP 5,142,000
Please amend your records accordingly.
EXHIBIT 21
BARCLAYS PLC
Notification of Major Interests in Shares
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing
shares to which voting rights are attached:
Barclays PLC
2. Reason for the notification (please tick the appropriate box or boxes):
Notification under DTR Sourcebook
3. Full name of person(s) subject to the notification
obligation:
Lloyds TSB Group plc
4. Full name of shareholders(s) (if different from 3.):
5. Date of the transaction and date on which the threshold is
crossed or reached:
N/A
6. Date on which the issuer notified:
N/A
7. Thresholds(s) that is/are crossed or reached:
N/A
8. Notified Details:
8. A: Voting rights attached to shares
Class/type of shares
Ord GBP 25p
GB0031348658
Situation previous to the Triggering transaction
Number of shares Number of Voting Rights
N/A N/A
Resulting situation after the triggering transaction
Number of shares Number of Voting Rights % of voting rights
Direct Direct Indirect Direct Indirect
115,517,454 115,517,454 228,437,740 1.766 3.493
8. B: Financial Instruments
TOTAL (A+B)
Number of voting rights % of voting rights
343,955,194 5.259%
9. Chain of controlled undertakings through which the voting
rights and/or the financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
Contact name for enquiries:
Lawrence Dickinson
Company Secretary
0207 116 8099
20 March 2007
EXHIBIT 22
20 March 2007
Director/PDMR shareholding: Disclosure and Transparency Rules 3.1.4R(1)(a) and
3.1.4R(1)(b)
The independent trustee of the Barclays Group (ESAS) Employees' Benefit Trust
(the "ESAS Trust") notified Barclays PLC ("the Company") on 19 March 2007 that
it had between 14 March 2007 and 16 March 2007 exercised its discretion and
released a total of 168,604 ordinary shares in Barclays PLC. None of the shares
released were in respect of an award made to a director of Barclays PLC.
Following these transactions, the trustees of all the Barclays Group employees'
benefit trusts hold a total of 208,844,689 ordinary shares in Barclays PLC. The
executive directors of Barclays PLC are amongst the potential beneficiaries
under these trusts and are therefore regarded for Companies Act purposes as
being interested in the Barclays PLC ordinary shares held in them.
EXHIBIT 23
20th March 2007
BARCLAYS PLC
In the Enron class action litigation that has been pending against Barclays in
Houston since 2002 (commonly known as the Newby litigation), The United States
Court of Appeals for the 5th Circuit yesterday issued an order reversing the
district court's ruling that the case against Barclays and two other financial
institutions could properly proceed. The Court of Appeals held that because no
proper claim against Barclays and the others had been alleged by the plaintiffs,
the case could not proceed against them. The plaintiffs have said they will
likely seek further appellate review of this decision, including by the United
States Supreme Court.
- ENDS -
Contacts:
Media Enquiries Investor Enquiries
Stephen Whitehead/Alistair Smith Mark Merson/James S Johnson
Tel: +44 (0) 20 7116 6060/6132 Tel: +44 (0) 20 7116 5752/2927
About Barclays
Barclays Bank PLC is a major global financial services provider engaged in
retail and commercial banking, credit cards, investment banking, wealth
management and investment management services. We are one of the largest
financial services companies in the world by market capitalisation. With over
300 years of history and expertise in banking, Barclays operates in over 60
countries and employs around 120,000 people, we move, lend, invest and protect
money for over 25 million customers and clients worldwide. For further
information about Barclays PLC please visit our website www.barclays.com.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of
Section 21E of the US Securities Exchange Act of 1934, as amended, and Section
27A of the US Securities Act of 1933, as amended, with respect to certain of
Barclays plans and its current goals and expectations relating to its future
financial condition and performance, in particular with respect to Barclays
Capital. These forward-looking statements can be identified by the fact that
they do not relate only to historical or current facts. Forward-looking
statements sometimes use words such as 'aim', 'anticipate', 'target', 'expect',
'estimate', 'intend', 'plan', 'goal', 'believe', or other words of similar
meaning. Examples of forward-looking statements include, among others,
statements regarding Barclays future financial position, income growth,
impairment charges, business strategy, projected levels of growth in the banking
and financial markets, projected costs, estimates of capital expenditures, and
plans and objectives for future operations.
By their nature, forward-looking statements involve risk and uncertainty because
they relate to future events and circumstances, including, but not limited to,
global as well as US economic and business conditions, market related risks such
as changes in interest rates and exchange rates, the policies and actions of
governmental and regulatory authorities, changes in legislation, and the impact
of competition - a number of which factors are beyond Barclays control. As a
result, Barclays actual future results may differ materially from the plans,
goals, and expectations set forth in Barclays forward-looking statements. Any
forward-looking statements made by or on behalf of Barclays speak only as of the
date they are made. Barclays does not undertake to update forward-looking
statements to reflect any changes in Barclays expectations with regard thereto
or any changes in events, conditions or circumstances on which any such
statement is based. The reader should, however, consult any additional
disclosures that Barclays has made or may make in documents it has filed or may
file with the SEC.
EXHIBIT 24
Publication of Final Terms
The following final terms has been approved by the UK Listing Authority and is
available for viewing:
Final Terms in relation to Barclays Bank PLC's issue of U.S.$1,500,000,000
Floating Rate Subordinated Step-Up Callable Notes due 2017 under the Barclays
Bank PLC GBP20,000,000,000 Debt Issuance Programme
To view the full document, please paste the following URL into the address bar
of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/5881t_-2007-3-23.pdf
For further information, please contact
Barclays Treasury
1 Churchill Place
Canary Wharf
London E14 5HP
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Final Terms may be addressed
to and/or targeted at persons who are residents of particular countries
(specified in the Prospectus dated 8 June 2006 for the Barclays Bank PLC
GBP20,000,000,000 Debt Issuance Programme) only and is not intended for use and
should not be relied upon by any person outside these countries. Prior to
relying on the information contained in the Final Terms you must ascertain from
the Prospectus whether or not you are part of the intended addressees of the
information contained therein.
The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act"), or any relevant
securities laws of any state of the United States and are subject to U.S. tax
law requirements. Subject to certain exceptions, the Notes may not be offered,
sold or delivered in the United States or to or for the account or benefit of
U.S. persons, as such terms are defined in Regulation S under the Securities
Act.
Your right to access this service is conditional upon complying with the above
requirement.
EXHIBIT 25
26 March 2007
Director/PDMR shareholding: Disclosure and Transparency Rules 3.1.4R(1)(a) and
3.1.4R(1)(b)
1. Following a recommendation made by Barclays PLC ("the Company") on the 20
February 2007, the independent trustee of the Barclays Group (PSP) Employees'
Benefit Trust (the "PSP Trust") notified the Company on 26 March 2007 that on 22
March 2007 it had resolved to grant the following awards under PSP to Directors
of the Company:
Director Allocation of performance Maximum number potentially
shares (a) releasable
Robert E Diamond Jr 934,516 2,803,548
Gary Hoffman 85,266 255,798
Frederik Seegers 136,426 409,278
John Varley 163,710 491,130
Note:
(a) Under PSP, awards are granted as a provisional allocation and do not give
rise to any entitlement to the shares. At the third anniversary, shares may
be released by the trustee subject to performance conditions being
satisfied.
The effective date of the grant of the awards was 21 March 2007 and the
calculation of the initial award allocation was based on a share price of
GBP7.33, which was the average price paid for the Company's shares by the
trustee between 20 February 2007 and 12 March 2007. No consideration was paid
for the grant of any award.
2. The independent trustee of the Barclays Group (ESAS) Employees' Benefit Trust
(the "ESAS Trust") notified the Company on 26 March 2007 that it had between
19 March 2007 and 23 March 2007 exercised its discretion and released a total
of 215,502 ordinary shares in the Company and between 19 March 2007 and 23
March 2007 it purchased 17,744 ordinary shares in the Company at an average
price of 733 pence per share. None of the shares released were in respect of
an award made to a Director of the Company.
Following these transactions, the trustees of all the Barclays Group
employees' benefit trusts hold a total of 208,646,931 ordinary shares in the
Company. The executive Directors of the Company are amongst the potential
beneficiaries under these trusts and are therefore regarded for Companies Act
purposes as being interested in the Company's ordinary shares held in them.
EXHIBIT 26
30 March 2007
Barclays PLC - Voting Rights and Capital
In conformity with the Disclosure and Transparency Rules, Barclays PLC's issued
share capital consists of 6,539,680,096 ordinary shares with voting rights and
875,000 staff shares with voting rights as at 21 March 2007. There are no
ordinary shares held in Treasury.
Therefore, the total number of voting rights in Barclays PLC is 6,540,555,096.
The above figure (6,540,555,096) may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, Barclays PLC under the
FSA's Disclosure and Transparency Rules.